Payment overview · 2025
General Payments
$65.60
4 reported records · 3 companies
Healthcare provider profile · identity verified
Jonathan Barry Dixon, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · SOMERSET, KY · NPI 1609840073
Verified facts
What the public records show
CMS Open Payments records show Jonathan Barry Dixon, M.D. received $65.60 in general payments during 2025 across 4 reported records.
Axsome Therapeutics, Inc. accounted for 52.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Paxlovid.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 117 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $34.50 | 52.6% | 2 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $17.47 | 26.6% | 1 | 2025 |
| Cipher Pharmaceuticals US LLC | Unresolved — no canonical attribution shown | $13.63 | 20.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $65.60 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $34.50 | 2 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $17.47 | 1 | 2025 |
Source payment records
|
|||||
| Natroba Normalized: natroba |
Drug | Cipher Pharmaceuticals US LLC | $13.63 | 1 | 2025 |
Source payment records
|
|||||
| Spinosad Normalized: spinosad |
Drug | Cipher Pharmaceuticals US LLC | $13.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| PAXLOVID paxlovid |
2025 | Paxlovid | 2024 | 15 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
117 | 23 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
15 | 15 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 650 | 107 |
| Lisinopril | Lisinopril | 492 | 104 |
| Atorvastatin Calcium | Atorvastatin Calcium | 487 | 112 |
| Omeprazole | Omeprazole | 435 | 84 |
| Metformin Hcl | Metformin Hcl | 393 | 80 |
| Pravastatin Sodium | Pravastatin Sodium | 343 | 75 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 340 | 89 |
| Citalopram Hbr | Citalopram Hydrobromide | 314 | 56 |
| Amlodipine Besylate | Amlodipine Besylate | 313 | 72 |
| Pantoprazole Sodium | Pantoprazole Sodium | 281 | 61 |
| Gabapentin | Gabapentin | 266 | 43 |
| Meloxicam | Meloxicam | 252 | 66 |
| Hydrochlorothiazide | Hydrochlorothiazide | 232 | 51 |
| Losartan Potassium | Losartan Potassium | 216 | 55 |
| Azithromycin | Azithromycin | 213 | 168 |
| Buspirone Hcl | Buspirone Hcl | 203 | 37 |
| Sertraline Hcl | Sertraline Hcl | 200 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 186 | 35 |
| Glimepiride | Glimepiride | 176 | 33 |
| Furosemide | Furosemide | 175 | 45 |
| Donepezil Hcl | Donepezil Hcl | 166 | 34 |
| Simvastatin | Simvastatin | 163 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 156 | 37 |
| Metoprolol Succinate | Metoprolol Succinate | 154 | 37 |
| Amoxicillin | Amoxicillin | 150 | 104 |
| Metoprolol Tartrate | Metoprolol Tartrate | 150 | 38 |
| Lorazepam | Lorazepam | 138 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 129 | 31 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 122 | 78 |
| Potassium Chloride | Potassium Chloride | 122 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 121 | 29 |
| Tramadol Hcl | Tramadol Hcl | 119 | 21 |
| Trazodone Hcl | Trazodone Hcl | 119 | 18 |
| Eliquis | Apixaban | 117 | 23 |
| Carvedilol | Carvedilol | 114 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 107 | 34 |
| Zolpidem Tartrate | Zolpidem Tartrate | 105 | 16 |
| Famotidine | Famotidine | 104 | 20 |
| Alprazolam | Alprazolam | 102 | 14 |
| Ibuprofen | Ibuprofen | 99 | 17 |
| Atenolol | Atenolol | 95 | 20 |
| Amitriptyline Hcl | Amitriptyline Hcl | 94 | 15 |
| Methocarbamol | Methocarbamol | 90 | 22 |
| Clonazepam | Clonazepam | 86 | 13 |
| Ozempic | Semaglutide | 85 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 82 | 15 |
| Prednisone | Prednisone | 82 | 38 |
| Montelukast Sodium | Montelukast Sodium | 79 | 11 |
| Mounjaro | Tirzepatide | 77 | 13 |
| Ezetimibe | Ezetimibe | 76 | 15 |
| Synthroid | Levothyroxine Sodium | 76 | 17 |
| Januvia | Sitagliptin Phosphate | 75 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 74 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 72 | 15 |
| Allopurinol | Allopurinol | 64 | 14 |
| Doxepin Hcl | Doxepin Hcl | 62 | suppressed |
| Celecoxib | Celecoxib | 61 | 17 |
| Cephalexin | Cephalexin | 60 | 50 |
| Lansoprazole | Lansoprazole | 60 | 11 |
| Glipizide Er | Glipizide | 58 | 11 |
| Nifedipine Er | Nifedipine | 58 | 12 |
| Pregabalin | Pregabalin | 58 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 57 | 30 |
| Warfarin Sodium | Warfarin Sodium | 56 | 13 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 55 | 11 |
| Fluconazole | Fluconazole | 54 | 38 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 53 | suppressed |
| Phenobarbital | Phenobarbital | 53 | suppressed |
| Acarbose | Acarbose | 49 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 49 | suppressed |
| Cefdinir | Cefdinir | 49 | 42 |
| Finasteride | Finasteride | 49 | suppressed |
| Lovastatin | Lovastatin | 47 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 46 | suppressed |
| Bumetanide | Bumetanide | 45 | suppressed |
| Mupirocin | Mupirocin | 45 | 37 |
| Bupropion Xl | Bupropion Hcl | 44 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 44 | 36 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 43 | 14 |
| Nystatin | Nystatin | 43 | 14 |
| Promethazine Hcl | Promethazine Hcl | 43 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 42 | 11 |
| Doxazosin Mesylate | Doxazosin Mesylate | 41 | suppressed |
| Mirtazapine | Mirtazapine | 41 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 41 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 40 | suppressed |
| Topiramate | Topiramate | 40 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 39 | 11 |
| Meclizine Hcl | Meclizine Hcl | 39 | 17 |
| Metoclopramide Hcl | Metoclopramide Hcl | 39 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 39 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 37 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 35 | suppressed |
| Gemfibrozil | Gemfibrozil | 35 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 34 | 28 |
| Estradiol | Estradiol | 34 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 32 | suppressed |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 31 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 31 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 30 | suppressed |
| Spironolactone | Spironolactone | 30 | suppressed |
| Diazepam | Diazepam | 29 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 29 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 29 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 26 | suppressed |
| Baclofen | Baclofen | 25 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 25 | 17 |
| Metolazone | Metolazone | 25 | 12 |
| Acyclovir | Acyclovir | 24 | 20 |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 24 | suppressed |
| Levetiracetam | Levetiracetam | 24 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 24 | suppressed |
| Valsartan | Valsartan | 24 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 23 | suppressed |
| Glipizide | Glipizide | 23 | suppressed |
| Hydrocortisone | Hydrocortisone | 23 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 23 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 23 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 23 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Etodolac | Etodolac | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 21 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 21 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 21 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 20 | suppressed |
| Temazepam | Temazepam | 20 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | 15 |
| Carbamazepine | Carbamazepine | 19 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 19 | suppressed |
| Risperidone | Risperidone | 19 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 19 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 17 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 17 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Lactulose | Lactulose | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 16 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 15 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 15 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 15 |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Felodipine Er | Felodipine | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Nadolol | Nadolol | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Xifaxan | Rifaximin | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Armour Thyroid | Thyroid,pork | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $65.60 · 4 records | Axsome Therapeutics, Inc. | Auvelity, Natroba, PAXLOVID, Spinosad | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Paxlovid play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error